Legislative Council Fifty-Third Parliament, Second Session (53-2) 53 2 Parliament of South Australia Legislative Council published Answers to Questions SA Pathology SA Pathology The Hon. K.L. VINCENT Legislative Council SA Pathology In reply to the Hon. K.L. VINCENT (1 December 2016). The Hon. I.K. HUNTER Legislative Council Minister for Sustainability, Environment and Conservation, Minister for Water and the River Murray, Minister for Climate Change SA Pathology The Hon. I.K. HUNTER (Minister for Sustainability, Environment and Conservation, Minister for Water and the River Murray, Minister for Climate Change): The Minister for Health has received the following advice: 1.	The review undertaken by Ernst & Young included a recommendation to 'Explore opportunities to contest regional services'. After consideration of the feedback received following consultation, this recommendation was not adopted or implemented. 2.	The majority of sputum samples will not be split. A small number of sputum samples for Mycology (fungus) and Tuberculosis (TB) analysis—which have special laboratory containment requirements—will be split. Note that SA Pathology operates South Australia's only PC3 laboratory and is a national reference centre for TB. The requirement to split a small number of sputum samples, in order to refer them to our central laboratory centre of excellence, remains unchanged from the current arrangement and reflects world-class practice. 3.	Regional revenue for year ending 30 June 2016 was $13,615,000 (regional total revenue)/$153,527,000 (total operating revenue) = 8.8 percent. 4.	Yes. 5.	The Efficiency Improvement Program is currently working through the detail of preferred laboratory configuration. Any full-time equivalent (FTE) changes or changes of hospital or laboratory sites are yet to be determined. 6.	As above, any FTE changes are yet to be determined. Since 2014, no employees, including those with a declared disability, have lost their jobs. 7.	Yes, which is why SA Pathology is focused on providing high quality diagnostic services. Our expert clinical pathologists, and world-leading researchers, work closely with our clinician colleagues and patients to reduce the burden of chronic disease. We are investing in cutting edge automation, such as the Roche Track system and Kiestra Microbiology platform at the new Royal Adelaide Hospital. Technology is the key to continuous improvement in the quality, consistency, timeliness and efficiency of laboratory testing. Automation also allows our people to focus on value-adding roles, helping us to futureproof our world-class pathology service.